Review Article

Ocular surface squamous neoplasia: Population demographics, pathogenesis and risk factors

Roland Hollhumer, Susan Williams, Pamela Michelow
African Vision and Eye Health | Vol 79, No 1 | a553 | DOI: https://doi.org/10.4102/aveh.v79i1.553 | © 2020 Roland Hollhumer, Susan Williams, Pamela Michelow | This work is licensed under CC Attribution 4.0
Submitted: 17 January 2020 | Published: 23 June 2020

About the author(s)

Roland Hollhumer, Department of Neurosciences, Division of Ophthalmology, University of the Witwatersrand, Johannesburg, South Africa; and, The Cornea Foundation, Johannesburg, South Africa
Susan Williams, Department of Neurosciences, Division of Ophthalmology, University of the Witwatersrand, Johannesburg, South Africa
Pamela Michelow, Cytology Unit, National Health Laboratory Service and Department of Anatomical Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Abstract

Background: Ocular surface squamous neoplasia (OSSN) is a unifying term used to describe conjunctival intra-epithelial neoplasia, squamous cell carcinoma in situ and invasive squamous cell carcinoma.

Aim: The aim of this article was to describe the demographics, clinical features, pathogenesis and risk factors of OSSN.

Method: A literature search was conducted using the search criteria ‘ocular surface squamous neoplasia’, ‘diagnosis’, ‘epidemiology’, ‘pathogenesis’ and ‘risk factors’.

Results: Ocular surface squamous neoplasia is the most common ocular tumour, with incidence rates ranging from 0.01 to 3.4 per 100 000 persons/year. There are two main patterns  of disease presentation: older white males in temperate climates where human immunodeficiency virus (HIV) and human papilloma virus (HPV) are not associated; and a younger patient population in tropical climates where HIV and HPV are more prevalent. The pathogenesis primarily revolves around ultraviolet B exposure and HPV infection that cause genetic mutations and uncontrolled cellular proliferation, whilst HIV infection and vitamin A impair tumour surveillance mechanisms. Ocular surface squamous neoplasia is first suspected clinically before formal confirmation of the diagnosis. Morphologically, it can be divided into three groups: placoid, nodular and diffuse. Placoid lesions can further be sub-divided into gelatinous, leukoplakic and papilliform lesions. Nodular lesions have the poorest prognosis, with the highest risk of metastasis and recurrence.

Conclusion: Ocular surface squamous neoplasia is a common ocular tumour associated with ultraviolet radiation, HPV and HIV infection. The pathogenesis revolves around acquired genetic mutations, unregulated cellular proliferation and impaired tumour surveillance mechanisms.


Keywords

conjunctival neoplasm; squamous cell cancer; human immunodeficiency virus; human papillomavirus; ultraviolet radiation

Metrics

Total abstract views: 7850
Total article views: 10725

 

Crossref Citations

1. Management and outcomes of ocular surface squamous neoplasia at a tertiary hospital, South Africa
Roland Höllhumer, Pamela Michelow, Elena Libhaber, Susan Williams
Eye  vol: 39  issue: 14  first page: 2713  year: 2025  
doi: 10.1038/s41433-025-03926-8

2. Ocular surface squamous neoplasia: management and outcomes
Roland Hӧllhumer, Susan Williams, Pamela Michelow
Eye  vol: 35  issue: 6  first page: 1562  year: 2021  
doi: 10.1038/s41433-021-01422-3

3. Update in the Diagnosis and Management of Ocular Surface Squamous Neoplasia (OSSN)
Michael Tsatsos, Chryseis Delimitrou, Ioannis Tsinopoulos, Nikolaos Ziakas
Journal of Clinical Medicine  vol: 14  issue: 5  first page: 1699  year: 2025  
doi: 10.3390/jcm14051699

4. The critical role of primary care clinicians in the early detection of ocular surface squamous neoplasia
Leendert Dekker, Jan F. Olivier, Klaus von Pressentin
South African Family Practice  vol: 67  issue: 1  year: 2025  
doi: 10.4102/safp.v67i1.6065

5. Stevens-Johnson Syndrome as a Risk Factor for Ocular Surface Squamous Neoplasia in a Pediatric Patient
Mauricio Muleiro-Alvarez, Angelica Hernandez-Solis, Gustavo Ortiz-Morales, Alejandro Navas, Nicolás Kahuam-López, Arturo Ramirez Miranda, Enrique O. Graue-Hernandez
Cureus  year: 2025  
doi: 10.7759/cureus.83919

6. AGE, SEX, AND TYPES OF OCCUPATION WITH HISTOPATHOLOGICAL TYPES IN PATIENTS WITH OCULAR SURFACE SQUAMOUS NEOPLASIA (OSSN) IN A TERTIARY HOSPITAL IN SURABAYA, INDONESIA
Stella Agatha Widjaja, Delfitri Lutfi, Linda Dewanti, Alphania Rahniayu, Fitria Kusumastuti
Majalah Biomorfologi  vol: 34  issue: 2  first page: 74  year: 2024  
doi: 10.20473/mbiom.v34i2.2024.74-82

7. Anterior Segment Optical Coherence Tomography for Conjunctival Lesions
Purna Nangia, Prithvi Mruthyunjaya
Advances in Ophthalmology and Optometry  vol: 11  issue: 1  first page: 83  year: 2026  
doi: 10.1016/j.yaoo.2026.03.004

8. Ocular surface squamous neoplasia: insights from 67 cases at a Quebec tertiary center
Rayan Tolba, Grace Lin, Sonia Callejo, Kanchan Sainani, Samir Jabbour, Laura Segal, Louis Racine, Mona Harissi-Dagher, Quynh Nguyen, Erika Massicotte, Patrick Daigle, Marie-Claude Robert
Canadian Journal of Ophthalmology  vol: 61  issue: 3  first page: 550  year: 2026  
doi: 10.1016/j.jcjo.2025.11.012

9. OSSN: An underrated neoplasia of the eye
Vanshika Khanna, Ram Kumar Jaiswal, Dipti Wahi
IP International Journal of Ocular Oncology and Oculoplasty  vol: 9  issue: 4  first page: 200  year: 2024  
doi: 10.18231/j.ijooo.2023.043

10. Role of Chemotherapy and Immunotherapy in Advanced T3 or T4 Ocular Surface Squamous Neoplasia: A Review of the Current Literature
Emily H. Jung, Nishita T. Sheth, Irene T. Lee, Julie A. Woodward, Christopher R. Dermarkarian
Current Ophthalmology Reports  vol: 13  issue: 1  year: 2024  
doi: 10.1007/s40135-024-00327-0

11. Association between human papillomavirus infection and ocular surface squamous neoplasia in South Africa
Roland Hollhumer, Susan Williams, Pamela Michelow
African Vision and Eye Health  vol: 85  issue: 1  year: 2026  
doi: 10.4102/AVEH.v85i1.1143

12. Benign limbal mass masquerading as ocular surface squamous neoplasia
Aarushi Saini, Jolly Rohatgi, Nampi Tadu, Agam Bhandari
The Pan-American Journal of Ophthalmology  vol: 5  issue: 1  year: 2023  
doi: 10.4103/pajo.pajo_86_23

13. The Epidemiology and Survival Outcomes of Adult Conjunctival Malignancies in Germany: A Decade-Long Population-Based Analysis (2009–2019)
Piotr Chlad, Vinodh Kakkassery, Armin Wolf, Christina V. Miller, Olaf Strauss, Ahmad Samir Alfaar
Ophthalmic Epidemiology  vol: 32  issue: 2  first page: 187  year: 2025  
doi: 10.1080/09286586.2024.2361170

14. Ocular surface squamous neoplasia: An overview
Rajendra Prakash Maurya, Vibha Singh, Kajal Pal, Shivangi Singh, Virendra P Singh, Kartika Anand
IP International Journal of Ocular Oncology and Oculoplasty  vol: 8  issue: 1  first page: 1  year: 2022  
doi: 10.18231/j.ijooo.2022.001

15. Clinicopathological Correlates of Ocular Surface Squamous Neoplasia
Timothy Kalas, Dimitrios Vagenas, Luke Maccheron, Nicholas Toalster
Ocular Oncology and Pathology  vol: 10  issue: 2  first page: 88  year: 2024  
doi: 10.1159/000538174

16. Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment
Irwin Leventer, Hartej Singh, Bahram Pashaee, Christian D. Raimondo, Chenab K. Khakh, Jonathan L. Martin, Binod Acharya, Qiang Zhang, Sara E. Lally, Carol L. Shields
Asia-Pacific Journal of Ophthalmology  vol: 13  issue: 2  first page: 100052  year: 2024  
doi: 10.1016/j.apjo.2024.100052

17. Demographics, clinical presentation and risk factors of ocular surface squamous neoplasia at a tertiary hospital, South Africa
Roland Hӧllhumer, Pamela Michelow, Susan Williams
Eye  vol: 37  issue: 17  first page: 3602  year: 2023  
doi: 10.1038/s41433-023-02565-1

18. Analysis of the Stability of 0.04% Mitomycin C Ophthalmic Solution under Various Storage Conditions
Yuma Nonomiya, Koki Yamaguchi, Yuta Yokoyama, Isana Nakajima, Ryusei Hara, Daigo Shoji, Tomomi Takiguchi, Kazumi Takehana, Aya Jibiki, Sayo Suzuki, Tomonori Nakamura, Hideki Tsuji, Masakazu Yamaguchi
The Keio Journal of Medicine  vol: 74  issue: 4  first page: 214  year: 2025  
doi: 10.2302/kjm.2025-0003-OA

19. Comparison of non-invasive diagnostic modalities for ocular surface squamous neoplasia at a tertiary hospital, South Africa
Roland Hӧllhumer, Pamela Michelow, Susan Williams
Eye  vol: 38  issue: 6  first page: 1118  year: 2024  
doi: 10.1038/s41433-023-02833-0

20. Clinicopathological characteristics of ocular surface squamous neoplasia: a 10-year review form a referral tertiary centre in Nigeria
Dauda Eneyamire Suleiman, Almustapha Aliyu Liman, Garba Dahiru Waziri, Yawale Iliyasu, Saad Aliyu Ahmed
International Ophthalmology  vol: 42  issue: 12  first page: 3905  year: 2022  
doi: 10.1007/s10792-022-02411-5

21. Molecular Analysis of the Ocular Microbiome Dominant Bacteria in Conjunctival Squamous Cell Carcinoma Patients
Samane Teymouri, Zahra Chegini, Masood Naseripour, Hossein Aghaei, Atieh Darbandi, Narjess Bostanghadiri, Shabnam Razavi
Iranian Journal of Medical Microbiology  vol: 17  issue: 6  first page: 654  year: 2023  
doi: 10.30699/ijmm.17.6.654

22. Chronic inflammation as a proposed risk factor for ocular surface squamous neoplasia
Sofia De Arrigunaga, Sarah Wall, Despoina Theotoka, Asaf Friehmann, Matthew Camacho, Sander Dubovy, Anat Galor, Carol L. Karp
The Ocular Surface  vol: 33  first page: 1  year: 2024  
doi: 10.1016/j.jtos.2024.02.006

23. Corneal Epithelial and Vascular Tumors in Domestic Species: Narrative Review of the Literature and Insights from New Cases (2016–2025)
Miriam Fossati, Gaia Beatrice Maria Bianchi, Chiara Giudice
Veterinary Sciences  vol: 13  issue: 3  first page: 258  year: 2026  
doi: 10.3390/vetsci13030258

24. Space radiation and risk for ocular surface malignancies: Exposure risk, current mitigation strategies, and management considerations for a mission to Mars
Raghuram V. Reddy, Joshua Ong, Ryung Lee, Ritu Sampige, Ethan Waisberg, C.Robert Gibson, John Berdahl, Thomas H. Mader
Life Sciences in Space Research  vol: 47  first page: 69  year: 2025  
doi: 10.1016/j.lssr.2025.06.002

25. Complete Response to Immunotherapy Using Pembrolizumab in a Patient With Conjunctival Squamous Cell Carcinoma With Nodal Metastasis
Janet Fan, Hila Goldberg, Carlos A. Torres-Cabala, John Stewart, Priyadharsini Nagarajan, Matthew Debnam, Eloisa Catherine Crouse, Tracy Lu, Renata Ferrarotto, Bita Esmaeli
Ophthalmic Plastic & Reconstructive Surgery  vol: 40  issue: 5  first page: e171  year: 2024  
doi: 10.1097/IOP.0000000000002683

26. Ocular surface squamous neoplasia in a patient following oral steroids for contralateral necrotising scleritis
Grace Yin, Shai Gendler, Joshua Teichman
BMJ Case Reports  vol: 15  issue: 12  first page: e253300  year: 2022  
doi: 10.1136/bcr-2022-253300

27. Effectiveness of 5-Fluorouracil Chemotherapy in Preventing Recurrence of Ocular Surface Squamous Neoplasia
Sumeya Ali Khan, Saad Ullah, Amna Manzoor, Fariha Taimur, Faizan Tahir, Murtaza Sameen
Journal of Rawalpindi Medical College  vol: 29  issue: 2  year: 2025  
doi: 10.37939/jrmc.v29i2.2668